Comgest Global Investors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $328M | Sell |
1,289,528
-54,703
| -4% | -$12.7M | 7.21% | 3 |
|
|
2026
Q1 | $329M | Sell |
1,344,231
-309,702
| -19% | -$72.1M | 7.16% | 2 |
|
|
2025
Q4 | $342M | Sell |
1,653,933
-164,767
| -9% | -$32.6M | 6.1% | 5 |
|
|
2025
Q3 | $337M | Sell |
1,818,700
-251,012
| -12% | -$43M | 5.97% | 6 |
|
|
2025
Q2 | $316M | Sell |
2,069,712
-89,108
| -4% | -$13.7M | 5.39% | 6 |
|
|
2025
Q1 | $358M | Buy |
2,158,820
+57,917
| +3% | +$9.06M | 6.39% | 7 |
|
|
2024
Q4 | $304M | Buy |
2,100,903
+3,714
| +0.2% | +$576K | 4.98% | 7 |
|
|
2024
Q3 | $340M | Buy |
2,097,189
+109,235
| +5% | +$17.4M | 4.87% | 8 |
|
|
2024
Q2 | $291M | Buy |
1,987,954
+127,133
| +7% | +$18.9M | 3.99% | 8 |
|
|
2024
Q1 | $294M | Buy |
1,860,821
+44,207
| +2% | +$7.04M | 4.1% | 7 |
|
|
2023
Q4 | $285M | Buy |
1,816,614
+5,585
| +0.3% | +$856K | 4.27% | 7 |
|
|
2023
Q3 | $282M | Buy |
1,811,029
+86,404
| +5% | +$14.3M | 4.83% | 6 |
|
|
2023
Q2 | $285M | Sell |
1,724,625
-20,113
| -1% | -$3.25M | 4.77% | 6 |
|
|
2023
Q1 | $270M | Sell |
1,744,738
-90,943
| -5% | -$14.7M | 5.07% | 6 |
|
|
2022
Q4 | $324M | Buy |
1,835,681
+359,176
| +24% | +$62M | 7.16% | 4 |
|
|
2022
Q3 | $241M | Buy |
1,476,505
+33,997
| +2% | +$5.75M | 5.31% | 6 |
|
|
2022
Q2 | $256M | Buy |
1,442,508
+98,501
| +7% | +$17.6M | 5.03% | 7 |
|
|
2022
Q1 | $238M | Sell |
1,344,007
-97,110
| -7% | -$16.5M | 3.72% | 9 |
|
|
2021
Q4 | $247M | Buy |
1,441,117
+38,080
| +3% | +$6.23M | 3.28% | 12 |
|
|
2021
Q3 | $227M | Buy |
1,403,037
+51,014
| +4% | +$8.7M | 2.97% | 15 |
|
|
2021
Q2 | $223M | Sell |
1,352,023
-164,670
| -11% | -$27.3M | 3.03% | 14 |
|
|
2021
Q1 | $249M | Buy |
1,516,693
+94,964
| +7% | +$15.4M | 3.82% | 12 |
|
|
2020
Q4 | $224M | Buy |
1,421,729
+70,845
| +5% | +$10.5M | 3.93% | 11 |
|
|
2020
Q3 | $201M | Buy |
1,350,884
+10,350
| +0.8% | +$1.53M | 3.01% | 14 |
|
|
2020
Q2 | $189M | Sell |
1,340,534
-48,422
| -3% | -$7.06M | 3.16% | 14 |
|
|
2020
Q1 | $182M | Sell |
1,388,956
-141,144
| -9% | -$20M | 3.72% | 12 |
|
|
2019
Q4 | $223M | Sell |
1,530,100
-17,300
| -1% | -$2.35M | 4.03% | 11 |
|
|
2019
Q3 | $200M | Buy |
1,547,400
+92,800
| +6% | +$12.2M | 4.08% | 11 |
|
|
2019
Q2 | $203M | Sell |
1,454,600
-187,600
| -11% | -$26M | 4.4% | 9 |
|
|
2019
Q1 | $230M | Buy |
1,642,200
+150,400
| +10% | +$20.1M | 5.03% | 8 |
|
|
2018
Q4 | $193M | Buy |
1,491,800
+840,100
| +129% | +$117M | 4.76% | 7 |
|
|
2018
Q3 | $90M | Buy |
651,700
+514,500
| +375% | +$68.4M | 2.02% | 17 |
|
|
2018
Q2 | $16.6M | Buy |
137,200
+16,800
| +14% | +$2.1M | 0.37% | 22 |
|
|
2018
Q1 | $15.4M | Buy |
120,400
+9,300
| +8% | +$1.26M | 0.34% | 22 |
|
|
2017
Q4 | $15.5M | Buy |
111,100
+74,500
| +204% | +$10.4M | 0.34% | 24 |
|
|
2017
Q3 | $4.76M | Buy |
36,600
+8,700
| +31% | +$1.15M | 0.11% | 39 |
|
|
2017
Q2 | $3.69M | Hold |
27,900
| – | – | 0.09% | 40 |
|
|
2017
Q1 | $3.47M | Sell |
27,900
-904,750
| -97% | -$108M | 0.09% | 41 |
|
|
2016
Q4 | $107M | Sell |
932,650
-59,200
| -6% | -$6.84M | 3.49% | 9 |
|
|
2016
Q3 | $117M | Sell |
991,850
-180,100
| -15% | -$21.8M | 3.49% | 10 |
|
|
2016
Q2 | $142M | Buy |
1,171,950
+23,900
| +2% | +$2.72M | 4.32% | 9 |
|
|
2016
Q1 | $124M | Buy |
1,148,050
+318,300
| +38% | +$33M | 4.23% | 10 |
|
|
2015
Q4 | $85.2M | Buy |
829,750
+114,510
| +16% | +$11.5M | 2.84% | 12 |
|
|
2015
Q3 | $66.8M | Buy |
715,240
+48,000
| +7% | +$4.64M | 2.53% | 12 |
|
|
2015
Q2 | $65M | Sell |
667,240
-9,400
| -1% | -$941K | 2.16% | 13 |
|
|
2015
Q1 | $68.1M | Sell |
676,640
-174,100
| -20% | -$17.7M | 2.12% | 13 |
|
|
2014
Q4 | $89M | Buy |
+850,740
| New | +$89.7M | 2.72% | 11 |
|
Other funds holding JNJ
AACR
ECSS
Comgest Global Investors's JNJ Position: Q2 2026 in Review
Comgest Global Investors reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q2 2026, selling an estimated $12.7M and leaving 1,289,528 shares worth $328M. The position accounts for 7.21% of the portfolio, ranked #3.
Comgest Global Investors first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $358M in Q1 2025. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Comgest Global Investors held 1,289,528 shares of Johnson & Johnson worth $328M as of Q2 2026.
- Comgest Global Investors sold 54,703 Johnson & Johnson shares in Q2 2026, an estimated $12.7M.
- Johnson & Johnson made up 7.21% of Comgest Global Investors's portfolio in Q2 2026, its #3 holding.
- Comgest Global Investors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
- Comgest Global Investors's Johnson & Johnson position peaked at $358M in Q1 2025.
- 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Comgest Global Investors's 13F filing for Q2 2026, filed 24 Jul 2026.